Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Austin Neuromuscular Center, explained in plain language.
This early-phase study tests the drug patisiran in 10 adults with a rare disease called wild-type ATTR amyloidosis that causes nerve damage. The goal is to see if patisiran can improve nerve function and quality of life over 24 months. Participants will have regular check-ups and…
Phase: EARLY_PHASE1 • Sponsor: Austin Neuromuscular Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC